To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment
Conditions: Psoriasis Interventions: Drug: Hemay005 Sponsors: Ganzhou Hemay Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Ixekizumab in Patients With Refractory Guttate Psoriasis
Conditions: Guttate Psoriasis Interventions: Biological: Ixekizumab Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage
Conditions: Psoriasis Interventions: Drug: Hemay005 Sponsors: Ganzhou Hemay Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Evaluation of TWEAK in Plaque Psoriasis and Psoriatic Arthritis Patients
Conditions: Plaque Psoriasis Interventions: Drug: Adalimumab Sponsors: Egymedicalpedia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Ethoximod Pharmacokinetics In Healthy Subjects
Conditions: Psoriasis Interventions: Drug: Ethoximod Sponsors: Longevity Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients
Conditions: Plaque Psoriasis; Psoriasis Interventions: Drug: Cetaphil Sponsors: Galderma R&D Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Understanding Participation Habits Among Plaque Psoriasis Patients
Conditions: Plaque Psoriasis Sponsors: Power Life Sciences Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Bimekizumab in Plaque Psoriasis
Conditions: Plaque Psoriasis Interventions: Drug: Bimekizumab Sponsors: Icahn School of Medicine at Mount Sinai; UCB Pharma; Psoriasis Treatment Center of Central New Jersey Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)
Conditions: Moderate Plaque Psoriasis Interventions: Drug: Risankizumab; Drug: Deucravacitinib Sponsors: AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Combination of Sotyktu and Enstilar for Plaque Psoriasis
Conditions: Psoriasis Interventions: Drug: Enstilar; Drug: Deucravacitinib Sponsors: Psoriasis Treatment Center of Central New Jersey Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases
Conditions: Psoriasis; Alopecia Areata; Hidradenitis Suppurativa; Vitiligo; Atopic Dermatitis Interventions: Behavioral: HautKompass Sponsors: Universit ätsklinikum Hamburg-Eppendorf; German Federal Ministry of Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
Conditions: Generalized Pustular Psoriasis; Erythrodermic Psoriasis Interventions: Drug: TAK-279 Sponsors: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo
Conditions: Alopecia Areata; Vitiligo; Atopic Dermatitis; Psoriasis Interventions: Other: Observational Sponsors: Blueskin AS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
New Data Shows JNJ-2113, the First and Only Investigational Targeted Oral Peptide, Maintained Skin Clearance in Moderate-to-Severe Plaque Psoriasis Through One Year
SAN DIEGO (March 9, 2024)– Johnson& Johnson today announced the first data from FRONTIER 2, the long-term extension of the Phase 2b FRONTIER 1 clinical trial evaluating JNJ-2113, the first and only investigational targeted oral peptide... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 9, 2024 Category: Pharmaceuticals Source Type: clinical trials
A Herbal Compound for Psoriasis
Conditions: Psoriasis; Inflammation; Skin Diseases Interventions: Dietary Supplement: ZAX.1400.P03; Drug: Placebo Sponsors: Fasa University of Medical Sciences; Zarrin Avaye Kowsar Salamat (ZAX company) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
